Skip to main content
. 2020 Sep 24;16(9):e1008191. doi: 10.1371/journal.pcbi.1008191

Table 5. Summary of benchmark chemicals analyzed in this work.

The ER activity information is adapted from Judson et al. [6].

CASRN Compound Name ER Activity [6] Potency [6]
140-66-9 4-(1,1,3,3-Tetramethylbutyl)phenol Agonist Weak
599-64-4 4-Cumylphenol Agonist Weak
521-18-6 5α-Dihydrotestosterone Agonist Weak
57-91-0 17α-Estradiol Agonist Moderate
57-63-6 17α-Ethinyl estradiol Agonist Strong
58-18-4 17α-Methyltestosterone Agonist Very weak
50-28-2 17β-Estradiol Agonist Strong
520-36-5 Apigenin Agonist Very weak
85-68-7 Butylbenzyl phthalate Agonist Very weak
80-05-7 Bisphenol A Agonist Weak
77-40-7 Bisphenol B Agonist Weak
480-40-0 Chrysin Agonist Very weak
486-66-8 Daidzein Agonist Weak
117-81-7 Diethylhexyl phthalate Agonist Very weak
84-74-2 Di-n-butyl phthalate Agonist Very weak
115-32-2 Dicofol Agonist Very weak
56-53-1 Diethylstilbestrol Agonist Strong
53-16-7 Estrone Agonist Moderate
120-47-8 Ethylparaben Agonist Very weak
60168-88-9 Fenarimol Agonist Very weak
446-72-0 Genistein Agonist Weak
520-18-3 Kaempferol Agonist Very weak
143-50-0 Kepone Agonist Weak
84-16-2 meso-Hexestrol Agonist Strong
72-43-5 Methoxychlor Agonist Very weak
789-02-6 o,p'-DDT Agonist Weak
104-40-5 p-n-Nonylphenol Agonist Very weak
72-55-9 p,p'-DDE Agonist Very weak
68392-35-8 4-Hydroxytamoxifen Antagonist -
82640-04-8 Raloxifene Hydrochloride Antagonist -
10540-29-1 Tamoxifen Antagonist -
54965-24-1 Tamoxifen citrate Antagonist -
1912-24-9 Atrazine Inactive -
50-22-6 Corticosterone Inactive -
66-81-9 Cycloheximide Inactive -
13311-84-7 Flutamide Inactive -
52-86-8 Haloperidol Inactive -
52806-53-8 Hydroxyflutamide Inactive -
65277-42-1 Ketoconazole Inactive -
330-55-2 Linuron Inactive -
57-30-7 Phenobarbital sodium Inactive -
32809-16-8 Procymidone Inactive -
57-83-0 Progesterone Inactive -
50-55-5 Reserpine Inactive -
52-01-7 Spironolactone Inactive -